Comment on: Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo.

ABSTRACT:

SUBMITTER: Scandura C 

PROVIDER: S-EPMC7658122 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature